ArticleMolecular medicine reports2020
[Corrigendum] Angiopoietin‑like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes.
Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of this article, an interested reader drew to our attention that, in the Materials and methods section of the paper, on p. 2608 in the Immunofluorescence subsection, the authors had included a catalog number (cat no. 6487) that belonged to α‑actinin, not α‑smooth muscle actin (α‑SMA). After having investigated this matter with the authors, they were able to confirm that, although both α‑SMA and α‑actinin antibodies were employed in this study to investigate purification of the cardiomyocytes, the catalog number for α‑SMA should have been referenced as ab5694 from Abcam, and the catalog number for α‑actinin from Cell Signaling Technology is #6487. The authors were also able to confirm that staining with α‑SMA was presented in Fig. 1 of their article, and therefore the relevant catalogue number should have been listed on p. 2608 as ab5694 (Abcam) for α‑SMA, not #6487. The authors express their gratitude towards the reader who identified this error, and regret any inconvenience that this mistake has caused. [the original article was published in Molecular Medicine Reports 14: 2607‑2613, 2016; DOI: 10.3892/mmr.2016.5544].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.